Survival from cancer of the pancreas in England and Wales up to 2001

por Starling, N, Cunningham, D
Publicado 2008

Cost-effectiveness analysis of cetuximab/irinotecan vs active/best supportive care for the treatment of metastatic colorectal cancer patients who have failed previous chemotherapy...

por Starling, N, Tilden, D, White, J, Cunningham, D
Publicado 2007

Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses

por Sultana, A, Tudur Smith, C, Cunningham, D, Starling, N, Neoptolemos, J P, Ghaneh, P
Publicado 2008

Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy

por Sultana, A, Tudur Smith, C, Cunningham, D, Starling, N, Tait, D, Neoptolemos, J P, Ghaneh, P
Publicado 2007

Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer

por Rao, S, Starling, N, Cunningham, D, Benson, M, Wotherspoon, A, Lüpfert, C, Kurek, R, Oates, J, Baselga, J, Hill, A
Publicado 2008

Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience

por Waddell, T, Kotsori, A, Constantinidou, A, Yousaf, N, Ashley, S, Parton, M, Allen, M, Starling, N, Papadopoulos, P, O'Brien, M, Smith, I, Johnston, S
Publicado 2011

A phase II trial of preoperative chemotherapy with epirubicin, cisplatin and capecitabine for patients with localised gastro-oesophageal junctional adenocarcinoma

por Starling, N, Okines, A, Cunningham, D, Allum, W, Wotherspoon, A, Benson, M, Thompson, J, Thomas, J, Brown, G, Riddell, A, Stavridi, F, Ashley, S, Oates, J, Chau, I
Publicado 2009